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Summary 
Escherichia coli express fimbriae-associated adhesins through which they attach to mucosal cells 
and activate a cytokine response. The receptors for E. coli P fimbriae are the globoseries of gly- 
cosphingolipids;  Galc~l--)4Gall3-containing oligosaccharides bound to ceramide in the outer 
leaflet of the lipid bilayer. The receptors for type 1 fimbriae are mannosylated glycoproteins 
rather than glycolipids. This study tested the hypothesis that P-fimbriated E.  coli elicit a cyto- 
kine response through the release of ceramide in the receptor-bearing cell. We used the A498 
human kidney cell line, which expressed functional receptors for P and type 1 fimbriae and se- 
creted  higher levels  of interleukin  (IL)-6  when  exposed  to  the  fimbriated  strains  than  to 
isogenic nonfimbriated controls. P-fimbriated E.  coli caused the release of ceramide and in- 
creased  the  phosphorylation  of ceramide  to  ceramide  1-phosphate.  The  IL-6  response  to 
P-fimbriated E. coli was reduced by inhibitors ofserine/threonine kinases but not by other pro- 
tein kinase inhibitors.  In contrast, ceramide levels were not influenced by type 1-fimbriated 
E. coli, and the IL-6 response was insensitive to the serine/threonine kinase inhibitors. These 
results demonstrate that the ceramide-signaling pathway is activated by P-fimbriated E. coli, and 
that the receptor specificity of the P fimbriae influences this process. We propose that this acti- 
vation pathway contributes to the cytokine induction by P-fimbriated E. coli in epithelial cells. 
U 
ropathogenic  Escherichia  coli  attach  to  uroepithelial 
cells and elicit a cytokine response in those cells  (1). 
The molecular mechanisms of attachment are well defined, 
but the transmembrane signaling events that lead to cyto- 
kine activation are not known (2). 
Attachment is mediated by fimbriae, bacterial cell surface 
organelles with lectin domains (2). The lectins bind specifi- 
cally to  oligosaccharide  epitopes  exposed  on  cell  surface 
glycoproteins or glycolipids. Type 1 fimbriae bind terminal 
mannose residues, S fimbriae recognize sialic acid determi- 
nants,  and P  fimbriae bind Galod--)4Gall3-containing oli- 
gosaccharides, the carbohydrate portion of the globoseries 
glycosphingolipids (3-6). Fimbriae enhanced the epithelial 
cell cytokine response to bacteria (7, 8). P-fimbriated E. coli 
elicited a higher IL-6 response than isogenic strains lacking 
the fimbriae, and isolated P  fimbriae with an intact lectin 
domain  triggered  an  IL-6  response,  whereas  lectin-defi- 
cient fimbriae failed to  do so  (7).  Furthermore, cytokine 
activation  was  reduced  by  treatment  that  inhibited  gly- 
colipid receptor expression by the epithelial cells (9). 
These results suggested that fimbriae-glycolipid interac- 
tions may trigger transmembrane signaling events involved 
in the induction ofcytokine responses. The oligosaccharide 
receptor epitopes recognized by P  fimbriae are bound  to 
ceramide in the outer leaflet of  the lipid bilayer (6, 10). Until 
recently, glycolipids were not considered to participate in 
transmembrane  signaling,  partly because  of the  lack  of a 
transmembrane domain. Recent studies have demonstrated 
that ceramide can be released from sphingomyelin (SM) 1 by 
agonists like TNF-cx, IL-113, or 1oL,25-dihydroxyvitamin D3 
(11-13). TNF-a-induced ceramide release has been shown 
to activate NF-gB (11).  Ceramide can also undergo phos- 
phorylation through the action of membrane-bound serine/ 
threonine protein kinases,  and ceramide 1-phosphate fur- 
ther activated IL-2 in thymoma cells (12,  14). 
The aim  of this  study was  to  examine if P-fimbriated 
E. coli activate the ceramide-signaling pathway, and if this 
can contribute to the induction of an epithelial cytokine 
response by these bacteria. 
This study was presented  in the preliminary  form at the 8th International 
Congress of Mucosal Immunology, San Diego, July 1995 (abstract no. 
503). 
1Abb~viations used in this paper: cxMan, cc-methyl-D-mannoside;  CAPK, 
ceramide~activated  protein kinase; SM, sphingomyelin;  SMase, sphingo- 
myelinase. 
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Materials.  BSA,  cardiohpin  (bovine  heart),  ceramide  (type 
III), diethylenetriaminepentaacetic acid, genistein, goat anti-rab- 
bit  IgG  alkaline phosphatase,  Hepes,  K252a,  n-octyl-13-D-glu- 
copyranoside, PMA, sphingomyelinase (SMase) (Staphylococcus au- 
reus) (E.C. 3.1.4.12), staurosporine, and tyrphostin 51 were from 
Sigma Chemical Co. (St. Louis, MO). Diacylglycerol kinase  (E.C. 
2.7.1.107)  was from Calbiochem Corp. (San Diego, CA). Smooth 
LPS  (Salmonella  typhimurium  SH4809)  was  kindly provided by 
Professor  Alf Lindberg  (Karolinska Institute,  Stockholm,  Swe- 
den).  Fetal  calf serum,  t-glutamine,  nonessential  amino  acids, 
tkPMI  1640,  sodium pyruvate, and trypsin (E.C.3.4.21.4)  were 
from  GIBCO  BRL  Life  Technologies  Inc.  (Paisley,  Scotland, 
UK). Mouse anti-human mAbs (M8) and recombinant IL-6 were 
from  Central Laboratory of the  Red  Cross  Blood Transfusion 
Service (Amsterdam, The Netherlands). R_abbit polyclonal anti- 
human IL-6 antibodies were from Genzyme Corp.  (Cambridge, 
MA).  [32p]orthophosphate  (carrier free)  was from  ICN Radio- 
chemicals (Irvine, CA).  ["/-32p]ATP  (5,000 Ci/mmol) was from 
Amersham International (Amersham, UK).  3SS-protein labeling 
mix  (3,000  Ci/mmol) was from DuPont  NEN  (Boston,  MA). 
HPLC-grade solvents and EDTA (Titriplex III) were from Merck 
AG (Darmstadt, Germany). 
Bacteria.  E. coli strains with defined P and type 1 fimbrial ex- 
pression were used. E. coli AD110 was a clinical isolate from which 
the pap gene clusters,  encoding P fimbriae, has been cloned and 
sequenced. E. coli HB101/papsD11o  carried the plasmid pPIL110- 
35 with a 16-kb EcoR_I AD110 pap DNA insert in the EcoR.l site 
of pACYC184  (15).  E.  coli PKL4  (AAEC film vc31) carried the 
plasmid pPKL4 with thefim DNA sequences from E.  coli PC31 
(t6). E. coli HB101  was pap negative but hybridized with probes 
for thefim DNA sequences. E. coli AAEC was pap andfim nega- 
tive. Both strains were phenotypically negative for P  and type 1 
fimbriae.  For adhesion  testing  and  cytokine  activation, E.  coli 
AD110 was cultured on tryptic soy agar plates (TSA; Oxoid Ltd., 
Basingstoke, Hampshire, UK). E. coli HB101/pap~.D11O and E. coli 
PKL4 were cultured on TSA with tetracycline (10  I~g/ml) and 
ampillicin  (100  Ixg/ml),  respectively.  Adhesin  expression  was 
tested by hemagglutination using human  erythrocytes of blood 
group AlP1 and Ap erythrocytes as well as guinea pig erythrocytes 
(6).  P. fimbriae caused mannose-resistant agglutination of human 
AlP1  erythrocytes, which express the  globoseries of glycolipids, 
but not ofAp erythrocytes, which lack these glycohpids (2, 5, 6). 
Type 1 fimbriae caused mannose-sensitive agglutination of guinea 
pig  erythrocytes  that  was  inhibited  by  0t-methyl-o-mannoside 
(etMan; 0.1 M) (3). 
Epithelial  Cell Line.  The  human  epithelial  cell  line  A498 
(HTB44, human kidney carcinoma; American Type Culture Col- 
lection) was grown in KPMI 1640  supplemented with 5% FCS, 
1 mM  sodium pyruvate,  1 mM  nonessential amino  acids,  gen- 
tamicin (50  I~g/ml), and 2 mM L-glutamine. A stock culture was 
maintained  in  75-cm  2 culture  flasks  (Falcon Labware,  Becton 
Dickinson Ltd., Oxford, UK) at 37~  in a 5% CO 2 atmosphere 
and split weekly. 
Bacterial Adherence Assay.  A498 cells were detached by treat- 
ment with trypsin (0.25%) for 5 rain at room temperature or with 
0.5 mM EDTA at 37~  for 15 rain, harvested by centrifugation 
at 150 g for 7 rain, and washed by repeated cycles of centrifuga- 
don and resuspension in 60 mM PBS, pH 7.2. The epithelial cell 
suspension was mixed with bacteria (final concentration, 10  s cells 
and 109 bacteria/ml) and incubated for 45 rain at 37~  with end- 
over-end  rotation.  Unattached  bacteria  were  removed  by  re- 
peated  cycles of centrifugation and  resuspension  in  PBS.  The 
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number of bacteria attached to 40 cells was counted by interfer- 
ence contrast microscopy (Nikon Microphot-FX; Nikon, Tokyo, 
Japan). Adherence is expressed as the mean number of attached 
bacteria per cell. 
Cytokine Responses.  The cytokine responses of A498 cells to 
the difference agonists were analyzed using cells grown to conflu- 
ency in 24-well cell culture plates (Falcon). The medium was as- 
pirated and replaced by fresh RMPI containing E. coli (108 bacte- 
ria/ml), PMA,  (10  ng/ml),  or SMase  (0.01-1  U/ml).  Bacterial 
multiplication was bruited by residual gentamicin. 
The  effect  of protein  kinase  inhibitors on  the  cytokine re- 
sponse was tested by adding the inhibitors to the wells 10 rain be- 
fore the agonist. Staurosporine and K252a  (inhibitors of serine/ 
threonine kinases) were dissolved in 100% DMSO and diluted in 
R.PMI  1640  medium to a final concentration of 500  nM/well. 
Genistein and tyrphostin 51  (inhibitors of tyrosine phosphoryla- 
tion) were dissolved in DMSO and diluted in 1LPMI 1640 to a fi- 
nal concentration of 10 p~M/well. 
IL-6 Quantitation.  This  was by ELISA (17).  Briefly, mouse 
anti-human IL-6 mAbs (MS) (100  I~l/well, 5 I~g/rnl in 0.05 car- 
bonate buffer, pH 9.8) were used for coating. Samples from the 
A498 cell line or rhlL-6 were diluted in PBS containing 1% BSA 
(1% BSA-PBS). Bound  IL-6 was detected by addition of poly- 
clonal rabbit anti-human IL-6 antibodies followed by goat anti- 
rabbit IgG alkaline phosphatase. The standard curve was prepared 
using stock rhlL-6. The  activity of each sample was  compared 
with the standard curve and given as picograms IL-6 per milliliter. 
Glycosphingolipids.  These  were  extracted from  the  A498  cell 
line as described (18,  19).  Cells were detached from the culture 
flasks into medium by mechanical scraping with a rubber police- 
man,  collected by centrifugation at  150 g  for  10  rain,  and  ex- 
tracted with water/methanol (1:2) for 1 h at 65~  After centrifu- 
gation at 188 g for 10 min, the supernatant was collected, and the 
cell pellet was reextracted with methanol/chloroform (2:1).  The 
supernatants from each extraction were pooled, and the solvents 
were removed by evaporation under nitrogen. The lipids were 
subjected to mild alkaline hydrolysis by 0.2 M KOH in methanol 
for 2 h at room temperature. After neutralization with acetic acid, 
the extract was adjusted to chloroform/methanol/water (1:I0:9) 
and desalted on a 3-ml C-18 Bond Elute column (Analytichem 
International Inc., Harbor City, CA). Desalted lipids were sepa- 
rated by TLC on Kieselgel 60 aluminium-backed HPTLC plates 
(Merck).  The  reference  Glycolipid was  globotetraosylceramide 
from human erythrocytes (20). 
Bacterial Binding  to Glycolipids on TLC Plates.  Bacterial binding 
to Glycolipids and Glycolipid extracts was studied by the TLC 
overlay assay (10, 21). Bacteria were labeled by overnight growth 
in Luria broth containing 50 I~Ci of [3SS]methionine,  harvested 
by centrifugation at 2,000 g for 10 rain, and resuspended in PBS 
to ~I09 bacteria/ml. The glycolipid extracts were run on TLC 
plates in chloroform/methanol/water (60:35:8).  The plates were 
treated with  0.2%  (wt/vol)  polyisobutylmethacrylate in  diethyl 
ether for 1 rain and dried at room temperature. To reduce non- 
specific binding, the TLC plates were incubated with 2% BSA in 
PBS for 2 h. Without intermediate drying, the TLC plates were 
subsequently overlaid with the bacterial suspension and incubated 
for 2 h.  Unbound bacteria were removed by extensive washing 
with  BSA-PBS,  and bound  bacteria were  detected by  autora- 
diography. 
Release and Phosphorylation of Ceramide.  A498 cells labeled for 
72  h  with 75  }xCi/ml carrier-free 32p i  or  unlabeled A498  cells 
were detached with 0.25%  of trypsin and washed in  PBS.  Cell 
Signaling Table 1.  Fimbrial Expression  and Adhesion of E. coli Strains  Used in this Study 
Hemagglutination 
E. coli strain  Fimbrial genotype  Human Pl  Guinea pig 
Adhesion to A498 cells 
(bacteria/cell): -IxMan/+ (IMan 
E. coli AD110  pap+ ,  fim +  MR  -- 
E. coli HB101  pap-, fim +  --  -- 
E. coli HB 101/pap AD110  pap+,fim  +  MR  -- 
E. coli AAEC  pap-, fim-  --  -- 
E. coli PKL4  pap-, fim +  MS  MS 
34/50 
0/0 
4/9 
1/0 
21/1 
MR, Mannose resistant, not inhibited by (xMan; MS, mannose sensitive, inhibited by aMan. 
pellets were resuspended in tLPMI  1640  to a final concentration 
of 0.3  ￿  106 cells/m] and exposed to bacteria (108 CFU/ml) or 
SMase  (1.0  U/m]).  Free  ceramide  and  ceramide  1-phosphate 
were extracted as described (22). Briefly, the reactions were ter- 
minated at given time points by lipid extraction of the cell pellets 
with 1 m] of chloroform/methanol/concentration HC1 (100:100: 
1, vol/vol/vol) and 0.3 ml of  balanced salt solution (BSS; 135 mM 
NaC1, 4.5 mM KC1, 1.5 mM CaC12, 0.5 mM MgC12, 5.6 mM glu- 
cose, 10 mM Hepes, pH 7.2) containing 10 mM EDTA. The or- 
ganic phase was dried under N2, and lipids were subjected to mild 
alkaline hydrolysis by 0.1  M  KOH in methanol at 37~  for 1 h. 
Extracts from  unlabeled cells were  then  incubated with E.  coli 
diacylglycerol kinase as described by Preiss et al.  (23).  Ceramide 
1-phosphate from this reaction as well from prelabeled cells was 
isolated by TLC using chloroform/methanol/acetic acid (65:15:5, 
vol/vol/vol). Authentic ceramide 1-phosphate (RF 0.25) was iden- 
tified and quantitated by image analyzer (BAS  2000;  Fuji Film, 
Tokyo, Japan). The levels of free ceramide from unlabeled cells 
are  expressed as  picomoles of ceramide  1-phosphate/106  cells. 
Levels of ceramide 1-phosphate in prelabeled cells are expressed 
as the percentage of the levels in labeled cells exposed to medium 
alone. 
Assay of SMase Activity.  [N-14CHa]choline-labeled milk  SM 
(sp act 56  ~Ci/mg), synthesized by a demethylation-remethyla- 
tion procedure (24), was provided by Lena Nyberg (The Swedish 
Dairy Association, Lund, Sweden). SMase activity was measured 
according to Gatt (25) with modifications. 14C-SM stored in eth- 
anol was  dried under nitrogen and suspended in  0.15  M  NaC1 
containing 3 ~  bile salt mixture. Acid SMase activity was mea- 
sured by adding 25  I~1 of samples and 0.1  ml of 14C-SM  (40,000 
dpm) in 375 ~1 50 m_M Tris-HC1 buffer containing 0.15 M NaCI 
and 3 mlM bile salt mixture, pH 5.0. Neutral SMase activity was 
assayed by adding the  samples and  14C-SM  to  the  same buffer 
supplemented with 2 ~  Mg  a+ and 0.4% Triton X-100, pH 7.5. 
The  incubation was  performed at 37~  for 30  rain and  termi- 
nated by addition of 2  ml chloroform/methanol (2:1,  vol/vol). 
After centrifugation and phase partition, an aliquot of the upper 
phase was taken, and the radioactivity was determined by liquid 
scintillation counting. The activity was calculated and normalized 
as picomoles per hour per milligram protein. 
Results 
Fimbrial Expression  and  Cell Adhesion  of the E.  coli Strains. 
E.  coli AD110  expressed  P  fimbriae,  but  not  type  1  tim- 
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briae, under the culture conditions used in this study (Table 
1).  The attachment to the A498 cells was inhibited by pre- 
treatment  of the  bacteria with  the  receptor analogue glo- 
botetraosylceramide  (data  not  shown)  but  not  by o~Man. 
The recombinant strain E. coli HBlO1/pap,~Dlt o expressed P 
fimbriae (Table 1). E. coli PKL4 expressed type 1 but not P 
fimbriae, and the attachment to A498 cells was inhibited by 
cxMan. E. coli HB101  and E. coli AAEC did not agglutinate 
erythrocytes or attach to epithelial cells. The E.  coli strains 
attached in similar numbers to the A498 cell line and to ex- 
foliated human uroepithehal cells (data not shown). 
Bacterial Binding to  Glycolipids on A498  Cells.  Glycohp- 
ids  were  extracted  from  the  A498  cells  and  separated by 
TLC.  Staining with  anisaldehyde showed  the  presence  of 
glucosylceramides with  three  to  seven  sugar residues  (not 
shown).  Glycolipids with  receptor  activity for  P  fimbriae 
were detected by overlay with radiolabeled E.  coli (Fig.  1). 
E.  coli  HBlO1/papADllO  recognized glycohpids in  the  tri-, 
tetra-, and heptaglucosylceramide regions of the A498  ex- 
tract and bound to the globotetraosylceramide control, but 
not to  ceramide. The  type 1-fimbriated strain E.  coli PKL4 
did not  bind to  the  glycohpids on  TLC.  Neither  did the 
nonfimbriated  control  strains  E.  coti  HB101  or  E.  coli 
AAEC. 
Figure  1.  Bacterial binding  to  glycosphingolipids by TLC  overlay. 
(Lane  1)  Nonacid  glycosphingohpid extract fi'om the  A498 cell line. 
(Lane 2) Globotetraosylceramide. (Lane 3) Ceramide. TLC overlay with 
(A) radiolabeled P-fimbriated E. coli HBlO1/papsDllO; (B) Type 1-fimbri- 
ated E. coli PKL4. 5000" 
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Figure  2.  Cytokine  response (IL-6) of A498 cells exposed to PMA 
(~), E. coil PKL4 (type 1 fimbriated) (0), E. coli AD110 (I-]),  and E. coli 
HBlO1/pap/tol~  o (P fimbriated) (C)), E. coil HB101 (A), and E. coli AAEC 
(vector controls) ([]). Means +  SE l~om three separate experiments. 
and 24 h.  SMase induced a  dose-dependent IL-6 response 
that was  detectable above background by 2  h  (1.0  U/ml, 
Table 2)  and remained elevated after 6  and 24  h.  At 0.01 
U/ml,  a  response  was  detected only after 24  h.  Cells ex- 
posed to  SMase  (1.0  U/ml)  or E.  coli ADll0  (108  CFU/ 
ml) secreted similar levels of IL-6 secretion. Costimulation 
of the cells with both agonists had an additive effect on the 
IL-6 response (Table 2). 
Release  of Ceramide  in  Cells  Exposed  to  SMase  or E.  coli. 
The A498  cells were  exposed to medium, SMase  (1.0 U/ 
ml), P-fimbriated E.  coli type  1-fimbriated E.  coli, or non- 
fimbriated E. coli strains. Ceramide was extracted from cells 
harvested after 5,  10, 20, and 30 n'fin, and was phosphory- 
lated  in  vitro  using  the  diacylglycerol kinase  assay.  The 
product was separated by TLC,  and ceramide 1-phosphate 
was  quantitated by image analyzer. There was  a  rapid in- 
crease in the levels of free ceramide in cells exposed to SMase 
(151  _+  35%  at  20  min)  and  P-fimbriated E.  coti  (174  -+ 
22% for E.  coli AD110 and 125  +  18% for E.  coli HB101/ 
Attaching Bacteria  Elicit a Cytokine Response.  The  A498 
cells were exposed to E.  coli or PMA. Samples for cytokine 
measurements  were  withdrawn  at 0,  2,  6,  and  24  h.  The 
kinetics of the cytokine responses are shown in Fig. 2. The 
attaching E.  coli strains had elicited an IL-6 response above 
background by 2  h,  and the levels remained elevated at 6 
and 24  h.  The P- and type 1-fimbriated strains and PMA 
elicited  the  highest  levels  of  IL-6.  The  nonfimbriated 
strains E.  coli HB101  and E.  coli AAEC were poor activa- 
tors of IL-6. 
SMase Elicits an IL-6 Response in the A498  Cells.  The 
A498  cells were  exposed to  SMase  (1.0-0.01  U/ml)  and 
samples for  IL-6 quantitation  were  withdrawn  at  0,  2,  6, 
Table  2.  IL-6 Response ofA498 Cells to E. coli AD110 
and SMase 
IL-6 
Stimulant  0 h  2 h  6 h  24 h 
Control  194 
SMase (U/ml) 
1.0  191 
0.1  117 
0.01  123 
E. coli AD 110 
(108 CFU/ml)  186 
E. coli AD 110 
(108 CFU/ml) + 
SMase (U/ml) 
1.0  139 
0.1  116 
0.01  149 
~g  / mO 
161  320  566 
230  2,588  3,053 
204  377  4,002 
127  272  2,801 
966  3,201  3,469 
1,867  4,927  5,876 
1,178  3,900  3,930 
950  2,608  3,523 
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Figure 3.  (A) Kinetics of ceramide release in A498 cells exposed to 
E. coli AD110 (P fimbriated; [7), E. coil HB101 (nonfimbriated; O), and 
medium (C)). Means +  SE from four experiments. (B) Kinetics of cera- 
mide phosphorylation in A498 cells exposed to E. coli AD110 (P fimbri- 
ated; I-q), E. coil HB101 (nonfimbriated; (>), or medium (C)). Mean •  SE 
represent duplicate determinations from three experiments. 
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Figure  4.  Effect of protein kinase inhibitors on the 
IL-6 response ofA498 cells to E. coli AD110 and E. coli 
HB101/papt~11o  (P  fimbriated),  PMA,  and  E.  coli 
PKL4 (type 1 fimbriated). Agonist ([]),  +staurosporine 
(O),  +K252a (C)), +genistein (A), and +tyrphostin 51 
(I:l:l). Means +  SE from four experiments. 
papAoltO at 20 min) (Fig. 3 A). The type 1-fimbriated strain, 
and  the  nonfimbriated  E.  coli controls,  stimulated  lower 
levels of ceramide than the fimbriated strains  (89 +  32% for 
E. coli PKL4, 104 -+ 13% for E. coli AAEC, and 101  +  15% 
for E. coli HB101 at 20 rain). 
Phosphorylation  of Ceramide  in  Cells  Exposed  to  SMase  or 
E. coli.  The in vivo phosphorylation of ceramide was stud- 
ied in cells prelabeled with 32p  i for 72 h, and then exposed 
to  medium,  SMase  (1  U/ml),  P-fimbriated E.  coli, type 
1-fimbriated E.  coli, or nonfimbriated E.  coli. Cells were 
harvested at 5, 10, 20, and 30 min, ceramide was extracted, 
and the amount of ceramide 1-phosphate was determined 
(Fig.  3  B).  The control cells  had low levels of ceramide 
phosphorylation.  Increased  levels  were  observed  in  cells 
exposed to SMase and P-fimbriated E. coli for 20 min (223 
•  21% for SMase, 218  •  30% for E.  coli ADll0,  176  +-- 
29%  for  E. coli HBlO1/papAD11o).  SMase,  the  wild-type 
strain  ADll0,  and  the  P-fimbriated  recombinant  strain 
simulated higher ceramide 1-phosphate levels than the type 
1-fimbriated strain  and the  nonfimbriated strains  (133  + 
18% for E.  coti PKL4,  139  •  18% for E.  coli AAEC, and 
126 +-- 10% for E. coli HB101 at 20 rain). 
Effects  of Protein  Kinase  Inhibitors  on  Cytokine  Responses. 
Phosphorylation of ceramide has  been shown  to  involve 
serine/threonine protein kinases.  The cytokine response to 
E. coli and PMA was analyzed in cells pretreated for 10 rain 
with  staurosporine  or  K252a  (inhibitors  of serine/threo- 
nine-specific protein kinases)  and genistein  or tyrphostin 
51  (inhibitors of tyrosine-specific protein kinases).  The ki- 
netics of the IL-6 response in the presence and absence of 
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the inhibitors is shown in Fig.  4.  PMA-induced IL-6 re- 
sponses  were  inhibited by staurosporine  and  K252a,  but 
not by genistein or tyrphostin 51. The IL-6 response elic- 
ited by the P-firnbriated strains  E.  coli AD110 and E.  coli 
HBlO1/papaDno were inhibited by staurosporine and K252a, 
whereas genistein and tyrphostin 51 had no effect. In con- 
trast,  the IL-6 response induced by the type 1-fimbriated 
strain E. coti PKL4 was decreased by genistein and tyrphos- 
tin 51 but was not affected by staurosporine or K252a. 
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Figure  5.  IL-6 response of A498 cells to increasing concentrations of 
smooth LPS  from S.  typhimurium.  0.1  Ixg/ml ('~),  1.0  I~g/mt (l:l~),  10 
I~g/ml (A), 0.1  mg/ml (C)),  1.0 mg/ml (O), or medium (rq). Means + 
SE from these experiments. SMase Production by E. coli and A498 Cells.  The  SMase 
activity of the  E.  coli strains was analyzed in  culture  me- 
dium after filtration to remove bacterial cells. Low levels of 
acid SMase were detected in the bacteria before and after 
contact  with  the  A498  cells.  The  SMase  activity  of the 
A498  cells  was  analyzed before and after exposure  of the 
cells to E. coli. Both acid and neutral SMases were detected. 
A moderate increase in endogenous neutral SMase activity 
occurred after exposure to the bacteria. 
LPS Is  a  Poor Activator of Epithelial  Cell IL-6 Responses. 
The A498 cells were exposed to smooth LPS from S.  typh- 
imurium  (0.1,  1.0,  10,  and  100  ~g/ml).  Samples for IL-6 
quantitation  were withdrawn after 0,  2,  6, and 24 h  (Fig. 
5). The cells were negative for expression of surface CD-14 
as determined by flow cytometry. Addition of normal hu- 
man serum did not enhance the IL-6 response of the A498 
cells to LPS. 
Discussion 
Ceramide  has  recently become recognized  as  a  second 
messenger in the SM signal transduction pathway. It is re- 
leased from SM after the action of SMase,  an SM-specific 
form ofphospholipase C  (26).  In cells, ceramide may influ- 
ence growth and differentiation, regulate protein secretion, 
induce  DNA  fragmentation,  and  apoptosis,  and  enhance 
the  synthesis and secretion of cytokines  (14,  27-32).  The 
molecular mechanisms that control these diverse actions are 
not yet understood. More is known about the extracellular 
agonists that cause the release of ceramide. The hydrolysis 
of SM occurs rapidly upon exposure of the cells to exoge- 
nous SMase or to agonists that activate endogenous SMases. 
Such agonists include TNF-ot, IL-113, IFN-% let,25-dihy- 
droxyvitamin D3, and nerve growth factor (12-14, 33-36). 
The results of this study add P-fimbriated E. coli bacteria to 
the list of agonists that release ceramide and suggest that this 
signal transduction  pathway  contributes  to  the  bacterially 
induced cytokine response in epithelial cells. 
Two approaches were used to study E.  coli activation of 
the ceramide pathway in the A498 cells.  The release of ce- 
ramide was studied in unlabeled cells  and was quantitated 
by in vitro phosphorylation with diacylglycerol kinase (23). 
With this assay, P-fimbriated E. coli and SMase were shown 
to stimulate the A498  cells to release ceramide. The phos- 
phorylation of ceramide to ceramide 1-phosphate was quan- 
titated in cells prelabeled with 32p  i and then exposed to bac- 
teria or SMase  (22).  Extracted  ceramide  1-phosphate  was 
quantitiated after separation by TLC. With this assay, P-tim- 
briated E. coli and SMase were shown to induce similar in- 
creases  in  ceramide  /-phosphate  levels.  These  methods 
were previously used to study the release and phosphory- 
lation  of ceramide in EL4 and HL-60 cells  (14,  22).  The 
increases in free ceramide and in ceramide 1-phosphate ob- 
served in this study were of the same magnitude as the re- 
sponses to other agonists in previous studies.  The kinetics 
of the responses were also similar. This argues in favor of 
the  bacteria  as  direct  activators  of the  ceramide pathway 
and against a two-step process where the bacteria first acti- 
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vate a mediator that, in turn, causes ceramide release. The 
A498 kidney epithelial cells do not make TNF in response 
to bacteria, and the IL-1 response is intracellular rather than 
secreted. 
Several intracellular  targets for ceramide have been de- 
scribed.  The  ceramide-activated  protein  kinase  (CAPK) 
belongs to the serine/threonine protein kinases (14).  Other 
targets  include  a  serine/threonine--specific  protein  phos- 
phatase and an isoform of protein kinase C  (37,  38). In this 
study, we examined the effects of serine/threonine protein 
kinase inhibitors on the cytokine response of the A498 cells 
using PMA,  a known activator of these kinases, as a posi- 
tive  control.  Staurosporine  and  K252a  markedly reduced 
the IL-6 response to PMA and to P-fimbriated E. coli, sug- 
gesting that serine/threonine kinases are involved in the P 
fimbriae-induced  cytokine  response.  In  contrast,  tyrosine 
kinase inhibitors (genistein and tyrphostin 51) had no effect 
on the IL-6 response. 
There  were  interesting  differences  in  the  sensitivity  to 
protein kinase inhibitors between P- and type 1-fimbriated 
E. coli. The P- and type 1-fimbriated E. coli strains attached 
avidly to  A498  cells  and  induced  higher  IL-6 levels  than 
isogenic, nonfirnhriated strains.  Whereas the response to the 
P-fimbriated E.  coli was  blocked by inhibitors  of serine/ 
threonine protein kinases, the IL-6 response to type 1-tim- 
briated E. coIi was insensitive to these drugs. This suggested 
that the receptor specificity of the fimbriate and the nature 
of the  cell surface receptor influenced  the transmembrane 
signaling  pathway  leading  to  cytokine  activation.  The 
P-fimbriated E.  coli strains  induced  the  release and  phos- 
phorylation of ceramide, whereas type 1-fimbriated E.  coli 
activated IL-6 production through other as yet unidentified 
signaling pathways. Type 1 fimbriae bind secreted or cell- 
bound  glycoproteins  carrying  terminal  mannose  residues 
(3).  There is no evidence that  type  I  fimbriae bind cera- 
mide-containing receptors or that mannose residues recog- 
nized  by the  type  I  fimbrial lectin  occur  on  glycolipids. 
The P-fimhriated E.  coti, on the other hand, recognize the 
Galotl---)4Gal[3-containing oligosaccharides bound to cera- 
mide in the outer leaflet of the lipid bilayer (2,  5, 6).  One 
might  speculate  that  the  P-fimbriated E.  coli may induce 
the release of ceramide from the receptor glycolipid rather 
than from SM. P fimbriae and type 1 fimbriae may also dif- 
fer in the ability to cause the release ofceramide from SM. 
Exogenous SMase was shown to be a potent activator of 
IL-6 production and to release ceramide in the A498 cells. 
SMases are produced by a variety of bacterial species. The 
S. aureus SMase used in this study was previously shown to 
cleave SM and activate the release of ceramide in different 
cell types (11, 22). Bacterial SMase production could there- 
fore be a mechanism of ceramide release by the bacteria. 
The E.  coli strains used in this study had low acid and no 
detectable neutral SMase activity. Bacterial SMase secretion 
or upregulation of cellular SMases therefore did not appear 
to  explain the  ceramide release and  IL-6 response of the 
A498 cells. Activation of endogenous SMase leads to cera- 
mide release in different cell types. Acid as well as neutral 
SMase activity were detected in the A498 cells. A moderate 
Signaling increase  in  neutral  but  not  acid  SMase  activity  was  ob- 
served  after  exposure  of the  cells  to  E.  coli.  The  possible 
differences  in activation  of endogenous  SMases  related  to 
fimbrial expression need to be explored. 
Ceramide  and LPS were  recently shown to have  suffi- 
cient structural homology that LPS could replace ceramide 
as an activator ofserine/threonine protein kinases like CAPK 
(39).  The E.  coli strains used in this study might thus acti- 
vate cytokine production through a direct effect of LPS on 
CAPK. Purified LPS was, however, a poor activator of ep- 
ithehal cell cytokine responses in this and in earlier studies, 
and the A498 cells lacked surface CD-14  (7,  40, 41).  The 
LPS-induced ceramide  phosphorylation was  shown  to be 
CD-14 dependent (39). 
Furthermore, if LPS were the principal activator of cera- 
mide 1-phosphate production and IL-6 responses, the P- and 
type 1-fimbriated E.  coli would be expected to deliver LPS 
to the surface with similar efficiency, The difference in ce- 
ramide release and sensitivity to serine/threonine kinase in- 
hibitors between the P- and type 1-fimbriated strains sug- 
gested that P fimbriate contributed in an LPS-independent 
manner to the response or presented LPS differendy to the 
cells.  Earlier  studies  have  suggested  that  P  fimbriae  carry 
LPS at the tip, as an integral part of the G adhesin complex, 
adjacent to the receptor-binding domain  (42).  This would 
provide  the  basis for a  dual  signal,  through the  glycohpid 
receptor and through LPS. Further studies  are required  to 
resolve these questions. 
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